News of Note—Seqirus, Fujifilm and more

A Fujifilm Diosynth partnership and flu vaccine effectiveness are among this week's news of note.

> Seqirus executives expect to break even this year and report that the flu vaccine company is on track to profitability. Sky News story

> Fujifilm Diosynth and Texas A&M University are collaborating as a Center for Innovation in Advanced Development and Manufacturing. Bryan-College Station Eagle story

> Flu vaccines were 48% effective overall last year, according to a study published in The New England Journal of Medicine. Study

> Former GlaxoSmithKline vaccine head Moncef Slaoui resigned from Intellia's board. Boston Business Journal story

> Vaxess, a preclinical vaccine biotech, picked up former Sanofi Pasteur head Wayne Pisano for its advisory board. Release

Suggested Articles

The scientific community has again been caught off guard and industry officials are talking about implementing better preventive measures.

Sanofi didn't hesitate to enter Zika vaccine R&D, and despite the associated scandal, the company is again jumping into emerging disease vaccine R…

NIH and Moderna will need a coronavirus vaccine manufacturer, and and no major pharmaceutical company has stepped up.